Successful management of familial hemophagocytic lymphohistiocytosis by the JAK 1/2 inhibitor ruxolitinib

Marois, L; Touzot, F; Haddad, E; Fernandez, I; Morin, MP; De Bruycker, JJ; Duval, M; Cellot, S; Teira, P; Bittencourt, H; Decaluwe, H

Decaluwe, H (corresponding author), CHU St Justine, Pediat Immunol & Rheumatol Div, Dept Pediat, 3175 Chem Cote St Catherine, Montreal, PQ H3T 1C5, Canada.

PEDIATRIC BLOOD & CANCER, ; ():